Patent · US Active

Peanut formulations and uses thereof

US10653773B2 · kind B2 · utility

5Cited by
4References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2018
Grant dateMay 19, 2020
Priority date
Expiry dateAug 23, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.